Abstract:Introduction Clinical trials are important for advancing medical knowledge and protocols are the core documents that facilitate their appraisal. The SPIRIT (Standard Protocol Items: Recommendations for Interventional Trials) checklist offers a framework for standardizing the quality and content of clinical trial protocols. Although there is a high growth in number of clinical trials investigating the efficacy and safety of various therapies, many still exhibit deficiencies in information contained in both their reports and protocols. The main objective for this study were to check the findability of intervertebral disc degeneration (IVD) clinical trial protocols and assessing their adherence to SPIRIT recommendations. Methods We included randomized controlled trials (RCTs) that investigated various therapeutic interventions for IVD provided they included a control group and reported at least one relevant clinical outcome. Studies were excluded if they were not recruiting, were observational, case reports, reviews, meta-analyses, editorials, or commentaries, or if they lacked complete data, such as missing results or a protocol. A search was conducted on ClinicalTrials.gov using terms related to IVD, covering the period from January 2013 to the present, aligning with the post-SPIRIT recommendation publication period. Data extraction was performed using a reduced SPIRIT checklist to assess adherence to protocol guidelines, with compliance measured across 64 key items. A narrative synthesis was conducted to summarize study characteristics, adherence levels and patterns by intervention and sponsor type. Results Adherence rates vary from 28.13% to 98.44% with a median of 48.44%. Heatmaps revealed heterogeneity, highlighting areas of consistent adherence and regions requiring improvement. High adherence was noted in inclusion criteria and outcome measurement, while lower in research ethics and funding declarations. Industry-sponsored studies demonstrated highest adherence in 'DRUG' (79.69%) and 'DEVICE' (62.50%) categories, while non-industry sponsors were most adherent in 'BIOLOGICAL' (50.00%) and 'OTHER' intervention categories. Discussion Our findings shows a critical need for findability of clinical trial protocols to assist in appraisal of interventions and enhanced adherence to SPIRIT guidelines among IVD clinical trials, for greater transparency and accuracy. Adherence is essential for ensuring high-quality evidence that can inform clinical practice and patient care in managing IVD. Keywords: SPIRIT guidelines, intervertebral disc degeneration, clinical trial protocols, adherence assessment, randomized controlled trials, protocol standardization, clinical evidence.

Enhancing quality and impact of early phase dose-finding clinical trial protocols: SPIRIT Dose-finding Extension (SPIRIT-DEFINE) guidance

Development of consensus-driven SPIRIT and CONSORT extensions for early phase dose-finding trials: the DEFINE study

SPIRIT and CONSORT extensions for early phase dose-finding clinical trials: the DEFINE (DosE-FIndiNg Extensions) study protocol

Enhancing reporting quality and impact of early phase dose-finding clinical trials: CONSORT Dose-finding Extension (CONSORT-DEFINE) guidance

SPIRIT-PRO Extension explanation and elaboration: guidelines for inclusion of patient-reported outcomes in protocols of clinical trials

Reporting of surrogate endpoints in randomised controlled trial protocols (SPIRIT-Surrogate): extension checklist with explanation and elaboration

SPIRIT extension and elaboration for n-of-1 trials: SPENT 2019 checklist

Guidelines for cellular and molecular pathology content in clinical trial protocols: the SPIRIT-Path extension

Protocol of the CONSORT and SPIRIT Extension for multicenter clinical trials

SPIRIT: A Seamless Phase I/II Randomized Design for Immunotherapy Trials

Standard Protocol Items for Clinical Trials with Traditional Chinese Medicine 2018: Recommendations, Explanation and Elaboration (SPIRIT-TCM Extension 2018)

Guidelines for reporting pediatric and child health clinical trial protocols and reports: study protocol for SPIRIT-Children and CONSORT-Children

Protocol for the development of SPIRIT and CONSORT extensions for randomised controlled trials with surrogate primary endpoints: SPIRIT-SURROGATE and CONSORT-SURROGATE

Methods used to develop the SPIRIT 2024 and CONSORT 2024 Statements

An update to SPIRIT and CONSORT reporting guidelines to enhance transparency in randomized trials

BOIN Suite: A Software Platform to Design and Implement Novel Early-Phase Clinical Trials

Time to STEP UP: methods and findings from the development of guidance to help researchers design inclusive clinical trials

How do trial teams plan for retention during the design stage of the trial? A scoping review protocol

Systematic Evaluation of the Patient-Reported Outcome (PRO) Content of Clinical Trial Protocols

AIDE: Adaptive intrapatient dose escalation designs to accelerate Phase I clinical trials

Assessing the adherence of intervertebral disc degeneration clinical trial protocols to SPIRIT guidelines